Choosing between percutaneous coronary intervention and coronary artery bypass graft surgery for nondiabetic patients with multivessel disease.
作者信息
Dwivedi Aeshita, Bangalore Sripal
机构信息
Leon H. Charney Division of Cardiology, Department of Medicine, New York University Langone Medical Center, New York, USA.
出版信息
J Thorac Dis. 2016 Nov;8(11):3028-3033. doi: 10.21037/jtd.2016.11.104.
Abstract
摘要
相似文献
1
Choosing between percutaneous coronary intervention and coronary artery bypass graft surgery for nondiabetic patients with multivessel disease.为患有多支血管病变的非糖尿病患者在经皮冠状动脉介入治疗和冠状动脉旁路移植手术之间做出选择。
J Thorac Dis. 2016 Nov;8(11):3028-3033. doi: 10.21037/jtd.2016.11.104.
2
Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.一项针对女性多支血管稳定型冠状动脉疾病三种治疗策略的随机对照临床试验的长期随访
Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):997-1001. doi: 10.1093/icvts/ivu288. Epub 2014 Sep 2.
3
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
4
Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.非糖尿病多血管病变患者冠状动脉血运重建后的长期死亡率。
J Am Coll Cardiol. 2016 Jul 5;68(1):29-36. doi: 10.1016/j.jacc.2016.04.034.
5
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.依维莫司洗脱支架与冠状动脉旁路移植术治疗糖尿病合并多支血管病变患者的疗效比较
Circ Cardiovasc Interv. 2015 Jul;8(7):e002626. doi: 10.1161/CIRCINTERVENTIONS.115.002626.
6
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.冠状动脉旁路移植术与多系统疾病多支架经皮冠状动脉介入治疗的一年结局：来自随机临床试验个体患者数据的荟萃分析
J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9. doi: 10.1016/j.jtcvs.2004.12.049.
7
Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.多支血管病变或左主干病变的糖尿病和非糖尿病患者中支架与旁路手术的长期疗效：5775 例患者个体数据的汇总分析。
Circ Cardiovasc Interv. 2012 Aug 1;5(4):467-75. doi: 10.1161/CIRCINTERVENTIONS.112.969915. Epub 2012 Aug 7.
8
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病：一项个体患者数据的荟萃分析。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
9
Narrowing the gap: early and intermediate outcomes after percutaneous coronary intervention and coronary artery bypass graft procedures in California, 1997 to 2006.缩小差距：1997年至2006年加利福尼亚州经皮冠状动脉介入治疗和冠状动脉旁路移植手术后的早期及中期结果
J Thorac Cardiovasc Surg. 2009 Nov;138(5):1100-7. doi: 10.1016/j.jtcvs.2009.03.069.
10
Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病冠心病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较：一项系统评价和荟萃分析。
Ren Fail. 2014 Sep;36(8):1177-86. doi: 10.3109/0886022X.2014.934178. Epub 2014 Jul 2.
本文引用的文献
1
Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.非糖尿病多血管病变患者冠状动脉血运重建后的长期死亡率。
J Am Coll Cardiol. 2016 Jul 5;68(1):29-36. doi: 10.1016/j.jacc.2016.04.034.
2
Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease.
N Engl J Med. 2015 Aug 6;373(6):582. doi: 10.1056/NEJMc1506944.
3
Trial of everolimus-eluting stents or bypass surgery for coronary disease.瑞舒伐他汀洗脱支架置入术或冠状动脉旁路移植术治疗冠心病的临床试验
N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16.
4
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2014年美国心脏病学会/美国心脏协会/美国胸外科医师协会/预防心血管护士协会/心血管造影和介入学会/胸外科医师学会对稳定型缺血性心脏病患者诊断和管理指南的重点更新：美国心脏病学会/美国心脏协会实践指南工作组、美国胸外科医师协会、预防心血管护士协会、心血管造影和介入学会及胸外科医师学会的报告
J Am Coll Cardiol. 2014 Nov 4;64(18):1929-49. doi: 10.1016/j.jacc.2014.07.017. Epub 2014 Jul 28.
5
Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?糖尿病患者冠状动脉搭桥手术与经皮冠状动脉介入治疗的疗效比较：新一代药物洗脱支架能否缩小差距？
Circ Cardiovasc Interv. 2014 Aug;7(4):518-25. doi: 10.1161/CIRCINTERVENTIONS.114.001346. Epub 2014 Jun 17.
6
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果：来自 PRODIGY 研究（支架内内膜增生分级后延长双联抗血小板治疗研究）的预先指定分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.
7
8
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.
9
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.依维莫司洗脱支架与裸金属支架治疗 ST 段抬高型心肌梗死（EXAMINATION）：一项随机对照试验的 1 年结果。
Lancet. 2012 Oct 27;380(9852):1482-90. doi: 10.1016/S0140-6736(12)61223-9. Epub 2012 Sep 3.
10
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.临界血流储备分数指导下的经皮冠状动脉介入治疗与稳定型冠心病的药物治疗。
N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27.
Zotero 插件